利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

36 条记录 (耗时 0.022 秒)

    NETWORK-BASED SELF-CHECKOUT
    2.
    发明申请
    NETWORK-BASED SELF-CHECKOUT 审中-公开
    基于网络的自检

    公开(公告)号：US20130254114A1

    公开(公告)日：2013-09-26

    申请号：US13428623

    申请日：2012-03-23

    申请人： Graeme Smith

    发明人： Graeme Smith

    IPC分类号： G06Q30/06 ,  G06Q20/40

    CPC分类号： G06Q30/06 ,  G06Q20/20 ,  G06Q20/201 ,  G06Q20/208 ,  G06Q20/3274 ,  G06Q20/3276 ,  G07G1/0054

    摘要： Techniques for network-based self-checkout are provided. A consumer of an establishment uses a mobile app to self-scan barcodes of items for purchase. A running list of the items is maintained by a network shopping manager. The consumer uses the app to purchase the items when desired and the shopping manager sends a code to the app to validate the purchase. When exiting the establishment, the app provides the code to a self-service checkout system and as the customer bags the items, each item is validated against the list without requiring any additional action on the part of the consumer.

    摘要翻译： 提供了基于网络的自检功能。 企业的消费者使用移动应用程序自行扫描要购买的物品的条形码。 项目的运行列表由网络购物经理维护。 消费者使用应用程序在需要时购买项目，购物经理将代码发送到应用程序以验证购买。 当退出企业时，应用程序将代码提供给自助结帐系统，并且随着客户包装物品，每个项目都对该列表进行验证，而不需要对消费者进行任何额外的操作。

    ATM inhibitors
    8.
    发明申请
    ATM inhibitors 失效
    ATM抑制剂

    公开(公告)号：US20060178361A1

    公开(公告)日：2006-08-10

    申请号：US11351052

    申请日：2006-02-09

    申请人： Marc Hummersone ,  Keith Menear ,  Laurent Rigoreau ,  Graeme Smith ,  Niall Martin ,  Roger Griffin

    发明人： Marc Hummersone ,  Keith Menear ,  Laurent Rigoreau ,  Graeme Smith ,  Niall Martin ,  Roger Griffin

    IPC分类号： A61K31/55 ,  A61K31/453 ,  C07D409/14

    CPC分类号： C07D409/04 ,  C07D409/14

    摘要： A compound of formula I: and isomers, salts, solvates, chemically protected forms, and prodrugs thereof, wherein: R1 and R2 together form, along with the nitrogen atom to which they are attached, an optionally substituted nitrogen containing heterocyclic ring having from 4 to 8 ring atoms; and R3 is selected from hydroxy and —NRN1RN2, where RN1 and RN2 are independently selected from hydrogen, optionally substituted C1-7 alkyl groups, optionally substituted C3-20 heterocyclyl groups and optionally substituted C5-20 aryl groups, or together form, along with the nitrogen atom to which they are attached, an optionally substituted nitrogen containing heterocyclic ring having from 4 to 8 ring atoms, and its use in inhibiting ATM.

    摘要翻译： 式I化合物及其异构体，盐，溶剂化物，化学保护形式及其前药，其中：R 1和R 2一起与氮原子一起形成 它们所连接的是具有4-8个环原子的任选取代的含氮杂环; R 3和R 3选自羟基和-NR N 1 N 2 N 2，其中R 11和R 10独立地选自氢， N 2独立地选自氢，任选取代的C 1-7烷基，任选取代的C 3-20杂环基和任选取代的C 5 -20个芳基，或者与它们所连接的氮原子一起形成具有4至8个环原子的任选取代的含氮杂环，以及其在抑制ATM中的用途。

    Phthalazinone derivatives
    9.
    发明申请
    Phthalazinone derivatives 有权

    公开(公告)号：US20060142293A1

    公开(公告)日：2006-06-29

    申请号：US11352178

    申请日：2006-02-10

    申请人： Niall Martin ,  Graeme Smith ,  Charles White ,  Roger Newton ,  Diane Douglas ,  Penny Eversley ,  Julia Vile

    发明人： Niall Martin ,  Graeme Smith ,  Charles White ,  Roger Newton ,  Diane Douglas ,  Penny Eversley ,  Julia Vile

    IPC分类号： A61K31/502

    CPC分类号： C07D401/12 ,  A61K31/50 ,  A61K31/502 ,  C07D237/32 ,  C07D403/12 ,  C07D405/12 ,  C07D409/12 ,  C07D413/12 ,  C07D417/12

    摘要： A method of treatment of a disease of the human or animal body mediated by PARP comprising administering to such a subject a therapeutically effective amount of a compound of formula: or an isomer, salt, solvate, chemically protected form, and prodrug thereof, wherein: A and B together represent an optionally substituted, fused aromatic ring; RC is represented by -L-RL, where L is of formula: —(CH2)n1-Qn2-(CH2)n3— wherein n1, n2 and n3 are each selected from 0, 1, 2 and 3, the sum of n1, n2 and n3 is 1, 2 or 3 and Q is selected from O, S, NH, C(═O) or —CR1R2—, where R1 and R2 are independently selected from hydrogen, halogen or optionally substituted C1-7 alkyl, or may together with the carbon atom to which they are attached form a C3-7 cyclic alkyl group, which may be saturated (a C3-7 cycloalkyl group) or unsaturated (a C3-7 cycloalkenyl group), or one of R1 and R2 may be attached to an atom in RL to form an unsaturated C3-7 cycloalkenyl group which comprises the carbon atoms to which R1 and R2 are attached in Q, —(CH2)n3— (if present) and part of RL; and RL is optionally substituted C5-20 aryl; and RN is selected from hydrogen, optionally substituted C1-7 alkyl, C3-20 heterocyclyl, and C5-20 aryl, hydroxy, ether, nitro, amino, amido, thiol, thioether, sulfoxide and sulfone.